DAFNA LifeScience Ltd

Quick Statistics:

Current Rank: 171
Current Score: 267
Current Rank: 171
All-time Average Rank: 173
All-time Average Score: 295
Max Drawdown: -20.93
Annualized Standard Deviation: 21.16
Year to Date Return: -5.62
5-Star Rating: 21.16

Recent Performance:

Month Rank Score
May / 2016 171 51 267 7 5.85% Unknown -3.94 109.56 $104,939,000
April / 2016 222 81 260 19 6.28% Unknown -8.41 99.89 $104,939,000
March / 2016 303 503 241 148 2.90% Unknown -15.34 101.00 $104,939,000
February / 2016 806 -96 93 -8 -6.36% Unknown -14.58 98.27
January / 2016 710 -531 101 -156 -12.93% Unknown -4.21 114.27
December / 2015 179 -141 257 -73 -6.80% Unknown 10.73 146.79 $90,571,000
November / 2015 38 65 330 30 6.75% Unknown 14.73 165.26 $103,407,000
October / 2015 103 76 300 43 1.69% Unknown 8.40 143.90 $95,372,000
September / 2015 179 -77 257 -32 -6.80% Unknown 10.73 146.79 $90,571,000
August / 2015 102 -45 289 -48 -3.55% Unknown 17.03 179.17 $98,609,000
July / 2015 57 1 337 16 3.26% Unknown 21.57 179.83 $102,630,000
June / 2015 58 37 321 2 1.64% Unknown 13.54 178.08 $98,775,000
May / 2015 95 53 319 26 0.92% Unknown 15.14 165.93 $96,822,000
April / 2015 148 -50 293 -25 -1.76% Unknown 15.33 151.34 $96,071,000
March / 2015 98 97 318 27 3.82% Unknown 7.29 165.15 $95,635,000
February / 2015 195 -24 291 11 5.01% Unknown -3.54 173.59 $93,500,000
January / 2015 171 -59 280 -28 1.88% Unknown -2.99 158.35 $90,872,000
December / 2014 112 56 308 7 1.73% Unknown 6.54 159.01 $88,967,000
November / 2014 168 -80 301 -16 0.86% Unknown 4.87 159.96 $87,824,000
October / 2014 88 198 317 40 3.88% Unknown 6.55 161.17 $87,107,000
September / 2014 286 -100 277 -25 -1.50% Unknown 2.74 131.65 $83,079,000
August / 2014 186 93 302 33 0.19% Unknown 9.03 148.76 $84,750,000
July / 2014 279 -164 269 -55 -3.56% Unknown 8.56 145.33 $74,399,000
June / 2014 115 19 324 12 3.07% Unknown 21.88 165.58 $81,740,000
May / 2014 134 153 312 44 1.09% Unknown 18.16 176.85 $78,717,000
April / 2014 287 -100 268 -35 -8.61% Unknown 19.36 183.04 $77,638,000
March / 2014 187 -144 303 -75 -6.66% Unknown 31.82 226.34 $86,689,000
February / 2014 43 -15 378 -5 5.61% Unknown 41.65 264.15 $91,016,000
January / 2014 28 105 383 54 11.89% Unknown 36.96 222.36 $83,415,000
December / 2013 133 -38 329 -17 0.13% Unknown 28.61 192.69 $71,384,000
November / 2013 95 47 346 23 2.48% Unknown 30.47 204.96 $67,468,000
October / 2013 142 -29 323 -10 0.16% Unknown 25.09 179.48 $63,768,000
September / 2013 113 7 333 33 4.54% Unknown 21.85 138.49 $60,694,000
August / 2013 120 -44 300 -40 -0.25% Unknown 21.30 115.04 $55,405,000
July / 2013 76 75 340 47 8.28% Unknown 26.39 116.68 $54,499,000
June / 2013 151 -21 293 -20 -0.08% Unknown 20.24 120.09 $43,317,000
May / 2013 130 16 313 11 2.12% Unknown 27.93 111.81 $43,476,000
April / 2013 146 32 302 3 0.93% Unknown 23.43 115.53 $41,775,000
March / 2013 178 -85 299 -16 0.30% Unknown 22.71 122.82 $41,287,000
February / 2013 93 0 315 New 2.11% Unknown 31.91 114.84 $39,701,000

Awards

This hedge fund has no awards.

Trophies

2013

Top 100 Hedge Fund February 2013
Top 100 Hedge Fund July 2013
Top 100 Hedge Fund November 2013

2014

Top 100 Hedge Fund January 2014
Top 100 Hedge Fund February 2014
Top 100 Hedge Fund October 2014

2015

Top 100 Hedge Fund March 2015
Top 100 Hedge Fund May 2015
Top 100 Hedge Fund June 2015
Top 100 Hedge Fund July 2015
Top 100 Hedge Fund November 2015

Superlatives

DAFNA LifeScience Ltd's best month was January 2014, ranked #28 with a HedgeScore of 383 earning a 11.89% positive return of $9,918,044.

DAFNA LifeScience Ltd's worst month was January 2016 , ranked #710 with a HedgeScore of 101 taking a -12.93% loss.

Graphs

Assets Under Management

Monthly Return Percentage

Return on Investment

Embed Options

Options: Quick Stats Recent Performance Trophies Superlatives Graphs

Obligatory disclaimer: All of our data is crawled from the web and our understanding is that all hedge fund data is self-reported, meaning the data is only as good as the discloser is honest, and we obviously can't vouch for that. HedgeFundRanks.com is not an investment advisor. Use our rankings at your own risk!